A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/56 (2006.01) A61K 31/565 (2006.01) A61K 31/57 (2006.01) A61K 31/58 (2006.01)
Patent
CA 2261689
This invention provides a method of contraception which comprises administering to a female of child bearing age for a combination of a progestin at a daily dosage of 40-500 µg trimegestone, 250 µg - 4 mg dienogest, or 250 µg - 4 mg drospirenone, and an estrogen at a daily dosage equivalent in estrogenic activity to 10-20 µg ethinyl estradiol for 23-25 days beginning on day 1 of the menstrual cycle, and wherein the same dosage of the progestin and estrogen combination is administered in each of the 23-25 days.
Méthode de contraception consistant à administrer à une femme en âge de procréer une association d'une progestine, selon une posologie quotidienne de 40-500 µg de trimégestone, 250 µg-4 mg de diénogest, ou 250 µg-4 mg de drospirénone, et d'un oestrogène selon une posologie quotidienne équivalant en activité oestrogène à 10-20 µg d'éthinyloestradiol, pendant 23-25 jours à partir du premier jour du cycle menstruel, la même posologie de l'association de progestine et d'oestrogène étant utilisée chaque jour pendant les 23-25 jours.
American Home Products Corporation
Torys Llp
Wyeth
LandOfFree
Monophasic contraceptive method and kit comprising a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monophasic contraceptive method and kit comprising a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monophasic contraceptive method and kit comprising a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1902590